Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Labetalol"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1288
Tytuł:
Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis.
Autorzy:
Ou M; Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China.
Zhang F; Department of Vascular Surgery, The People's Hospital of Qingdao Chengyang District, Qingdao, China.
Cui S; Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China.
Zhao S; Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China.
Yu Y; Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China.
Pokaż więcej
Źródło:
Hypertension in pregnancy [Hypertens Pregnancy] 2023 Dec; Vol. 42 (1), pp. 2209637.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Labetalol*/therapeutic use
Hypertension, Pregnancy-Induced*/drug therapy
Female ; Pregnancy ; Humans ; Nifedipine/therapeutic use ; Blood Pressure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA).
Autorzy:
Ashworth D; Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
Battersby C; Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
Bick D; Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
Green M; Action On Pre-Eclampsia, Evesham, UK.
Hardy P; National Perinatal Epidemiology Unit Clinical Trials Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Leighton L; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Magee LA; Institute of Women and Children's Health, King's College London, London, UK.
Maher A; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
McManus RJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Moakes C; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Morris RK; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Nelson-Piercy C; Obstetric Medicine, Guy's and St Thomas' Hospitals NHS Trust, London, UK.
Sparkes J; Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
Rivero-Arias O; National Perinatal Epidemiology Unit Clinical Trials Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Webb A; Clinical Pharmacology, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, UK.
Wilson H; Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
Myers J; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Chappell LC; Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK. .
Pokaż więcej
Źródło:
Trials [Trials] 2023 Sep 12; Vol. 24 (1), pp. 584. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Labetalol*/adverse effects
Pre-Eclampsia*
Ursidae*
Hypertension*/diagnosis
Hypertension*/drug therapy
Pregnancy ; Infant ; Infant, Newborn ; Animals ; Female ; Humans ; Nifedipine/adverse effects ; Antihypertensive Agents/adverse effects ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nicardipine versus Labetalol for Hypertension during Acute Stroke: A Systematic Review and Meta-Analysis.
Autorzy:
Hao F; Department of Neurology, Liaocheng People's Hospital, Shandong Province, China.
Yin S; Department of Operating Room, Liaocheng Veterans Hospital, Shandong Province, China.
Tang L; Department of Neurosurgery, Liaocheng People's Hospital, Shandong Province, China.
Zhang X; Department of Neurosurgery, Liaocheng People's Hospital, Shandong Province, China.
Zhang S; Department of Neurosurgery, Liaocheng People's Hospital, Shandong Province, China.
Pokaż więcej
Źródło:
Neurology India [Neurol India] 2022 Sep-Oct; Vol. 70 (5), pp. 1793-1799.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Labetalol*/therapeutic use
Labetalol*/adverse effects
Hypertension*/drug therapy
Stroke*/complications
Stroke*/drug therapy
Stroke*/diagnosis
Humans ; Nicardipine/therapeutic use ; Nicardipine/adverse effects ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/adverse effects ; Retrospective Studies ; Prospective Studies ; Blood Pressure ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparison of the efficacy of intravenous labetalol versus oral nifedipine in patients with severe pregnancy-induced hypertension beyond 30 weeks of gestation.
Autorzy:
Agarwal, Manika (AUTHOR)
Rukshana, Makakmayum (AUTHOR)
Basu, Ritisha (AUTHOR)
Shullai, Wansalan (AUTHOR)
Singh, Santa (AUTHOR)
Pokaż więcej
Źródło:
Journal of Family Medicine & Primary Care. Dec2023, Vol. 12 Issue 12, p3119-3122. 4p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.
Autorzy:
Shao Y; Department of Obstetrics and Gynecology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, China.
Gu S; Department of Obstetrics and Gynecology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, China.
Zhang X; Department of Obstetrics and Gynecology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, China.
Pokaż więcej
Źródło:
Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Oct 13; Vol. 2022, pp. 9317114. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Typ publikacji:
Randomized Controlled Trial; Journal Article; Retracted Publication
MeSH Terms:
Labetalol*/adverse effects
Hypertension, Pregnancy-Induced*/drug therapy
Hypertension, Pregnancy-Induced*/chemically induced
Hypertension*
Humans ; Female ; Pregnancy ; Nifedipine/adverse effects ; Blood Pressure ; Magnesium Sulfate/pharmacology ; Magnesium Sulfate/therapeutic use ; Antihypertensive Agents/adverse effects ; Placenta ; Blood Coagulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Uterine Ultrasound Doppler Hemodynamics of Magnesium Sulfate Combined with Labetalol in the Treatment of Pregnancy-Induced Hypertension Using Empirical Wavelet Transform Algorithm.
Autorzy:
Liu C; Department of Obstetrics, Taiyuan Maternal and Child Health Hospital, Taiyuan 030020, Shanxi, China.
Wang F; Department of Obstetrics, Taiyuan Maternal and Child Health Hospital, Taiyuan 030020, Shanxi, China.
Yin X; Department of Obstetrics, Taiyuan Maternal and Child Health Hospital, Taiyuan 030020, Shanxi, China.
Pokaż więcej
Źródło:
Computational intelligence and neuroscience [Comput Intell Neurosci] 2022 May 26; Vol. 2022, pp. 7951342. Date of Electronic Publication: 2022 May 26 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Pregnancy-Induced*/diagnostic imaging
Hypertension, Pregnancy-Induced*/drug therapy
Labetalol*/pharmacology
Labetalol*/therapeutic use
Algorithms ; Female ; Hemodynamics ; Humans ; Magnesium Sulfate/pharmacology ; Magnesium Sulfate/therapeutic use ; Pregnancy ; Wavelet Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Autorzy:
Wu HZ; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei China.
Cheng Y; Department of Pathology, Hebei University of Chinese Medicine, Shijiazhuang, Hebei China.
Yu D; Heart Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei China.
Li JB; Department of Obstetrics and Gynecology Two Branch, Hebei General Hospital, Shijiazhuang, Hebei China.
Jiang YF; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei China.
Zhu ZN; Department of Pharmacology, Hebei Medical University, Shijiazhuang, Hebei China.
Pokaż więcej
Źródło:
Hypertension in pregnancy [Hypertens Pregnancy] 2022 May; Vol. 41 (2), pp. 126-138. Date of Electronic Publication: 2022 Mar 31.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Hypertension*/drug therapy
Hypertension, Pregnancy-Induced*/drug therapy
Labetalol*/adverse effects
Antihypertensive Agents/pharmacology ; Blood Pressure ; Female ; Humans ; Hydralazine/pharmacology ; Hydralazine/therapeutic use ; Infant, Newborn ; Network Meta-Analysis ; Nifedipine/pharmacology ; Nifedipine/therapeutic use ; Pregnancy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Enantioseparation of five racemic N-alkyl drugs by reverse phase HPLC using sulfobutylether-β-cyclodextrin as a chiral mobile phase additive.
Autorzy:
Chen B; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, P. R. China.
You H; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, P. R. China.
Fang L; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, P. R. China.
Lin T; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, P. R. China.
Xu P; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, P. R. China.
Chu C; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, P. R. China.
Tong S; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, P. R. China.
Pokaż więcej
Źródło:
Journal of separation science [J Sep Sci] 2022 Jun; Vol. 45 (11), pp. 1847-1855. Date of Electronic Publication: 2022 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Labetalol*
Atropine ; Chromatography, High Pressure Liquid/methods ; Fluoxetine ; Indicators and Reagents ; Stereoisomerism ; Venlafaxine Hydrochloride ; beta-Cyclodextrins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
Autorzy:
Dublin S; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, United States of America.; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Idu A; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, United States of America.
Avalos LA; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.
Cheetham TC; School of Pharmacy, Chapman University, Irvine, California, United States of America.
Easterling TR; Department of Obstetrics & Gynecology, University of Washington, Seattle, Washington, United States of America.
Chen L; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, United States of America.
Holt VL; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Nance N; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.
Bider-Canfield Z; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, United States of America.
Neugebauer RS; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.
Reynolds K; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, United States of America.
Badon SE; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.
Shortreed SM; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 May 16; Vol. 17 (5), pp. e0268284. Date of Electronic Publication: 2022 May 16 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypertension, Pregnancy-Induced*/epidemiology
Infant, Newborn, Diseases*/drug therapy
Labetalol*/therapeutic use
Premature Birth*/drug therapy
Premature Birth*/epidemiology
Antihypertensive Agents/adverse effects ; Birth Weight ; Female ; Humans ; Infant ; Infant, Newborn ; Methyldopa/therapeutic use ; Nifedipine/therapeutic use ; Pregnancy ; Pregnancy Outcome/epidemiology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Severe hypertension in pregnancy.
Autorzy:
Wiles K; The Royal London Hospital, London, UK .
Damodaram M; Queen Charlotte's and Chelsea Hospital, London, UK.
Frise C; Oxford University Hospitals NHS Foundation Trust, Oxford, UK and Queen Charlotte's and Chelsea Hospital, London, UK.
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2021 Sep; Vol. 21 (5), pp. e451-e456.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/drug therapy
Hypertension*/epidemiology
Labetalol*/therapeutic use
Pre-Eclampsia*/drug therapy
Pre-Eclampsia*/epidemiology
Pregnancy Complications, Cardiovascular*/diagnosis
Pregnancy Complications, Cardiovascular*/drug therapy
Pregnancy Complications, Cardiovascular*/epidemiology
Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Blood Pressure ; Female ; Humans ; Pregnancy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
Autorzy:
Rezk M; Department of Obstetrics and Gynecology, Menoufia University , Shibin Al Kawm, Egypt.
Emarh M; Department of Obstetrics and Gynecology, Menoufia University , Shibin Al Kawm, Egypt.
Masood A; Department of Obstetrics and Gynecology, Menoufia University , Shibin Al Kawm, Egypt.
Dawood R; Department of Obstetrics and Gynecology, Menoufia University , Shibin Al Kawm, Egypt.
El-Shamy E; Department of Obstetrics and Gynecology, Menoufia University , Shibin Al Kawm, Egypt.
Gamal A; Department of Cardiology, Menoufia University , Shibin Al Kawm, Egypt.
Badr H; Department of Pediatrics, Menoufia University , Shibin Al Kawm, Egypt.
Pokaż więcej
Źródło:
Hypertension in pregnancy [Hypertens Pregnancy] 2020 Nov; Vol. 39 (4), pp. 393-398. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Retracted Publication
MeSH Terms:
Antihypertensive Agents/*therapeutic use
Blood Pressure/*drug effects
Hypertension/*drug therapy
Labetalol/*therapeutic use
Methyldopa/*therapeutic use
Adult ; Antihypertensive Agents/pharmacology ; Female ; Humans ; Hypertension/physiopathology ; Labetalol/pharmacology ; Methyldopa/pharmacology ; Pregnancy ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Use of a non-hepatic cell line highlights limitations associated with cell-based assessment of metabolically induced toxicity.
Autorzy:
Weyers C; Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa.; Biomedical Biotechnology Research Unit, Rhodes University, Grahamstown, South Africa.
Dingle LMK; Biomedical Biotechnology Research Unit, Rhodes University, Grahamstown, South Africa.; Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, South Africa.
Wilhelmi BS; Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, South Africa.
Edkins AL; Biomedical Biotechnology Research Unit, Rhodes University, Grahamstown, South Africa.; Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, South Africa.
Veale CGL; School of Chemistry and Physics, Pietermaritzburg Campus, University of KwaZulu-Natal, Scottsville, South Africa.
Pokaż więcej
Źródło:
Drug and chemical toxicology [Drug Chem Toxicol] 2020 Nov; Vol. 43 (6), pp. 656-662. Date of Electronic Publication: 2019 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Chlorpromazine/*toxicity
Cytochrome P-450 CYP3A/*metabolism
Epithelial Cells/*drug effects
Labetalol/*toxicity
Propranolol/*toxicity
Rosiglitazone/*toxicity
Activation, Metabolic ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Chlorpromazine/metabolism ; Cytochrome P-450 CYP3A/genetics ; Epithelial Cells/enzymology ; Epithelial Cells/pathology ; HEK293 Cells ; Humans ; Labetalol/metabolism ; Propranolol/metabolism ; Risk Assessment ; Rosiglitazone/metabolism ; Substrate Specificity ; Toxicity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations.
Autorzy:
Hafsa, Hafsa (AUTHOR)
Zamir, Ammara (AUTHOR)
Rasool, Muhammad Fawad (AUTHOR)
Imran, Imran (AUTHOR)
Saeed, Hamid (AUTHOR)
Ahmad, Tanveer (AUTHOR)
Alsanea, Sary (AUTHOR)
Alshamrani, Ali A. (AUTHOR)
Alruwaili, Abdullah H. (AUTHOR)
Alqahtani, Faleh (AUTHOR)
Pokaż więcej
Źródło:
Pharmaceutics. Nov2022, Vol. 14 Issue 11, p2362. 14p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Retrospective evaluation of labetalol as antihypertensive agent in dogs.
Autorzy:
Zublena F; Department of Veterinary Anaesthesia, Dick White Referrals, Six Mile Bottom, Station Farm, London Road, Six Mile Bottom, CB8 0UH, Cambridgeshire, UK. .
De Gennaro C; Department of Veterinary Anaesthesia, Dick White Referrals, Six Mile Bottom, Station Farm, London Road, Six Mile Bottom, CB8 0UH, Cambridgeshire, UK.
Corletto F; Department of Veterinary Anaesthesia, Dick White Referrals, Six Mile Bottom, Station Farm, London Road, Six Mile Bottom, CB8 0UH, Cambridgeshire, UK.
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2020 Jul 24; Vol. 16 (1), pp. 256. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents/*therapeutic use
Dogs/*surgery
Hypertension/*veterinary
Labetalol/*therapeutic use
Adrenalectomy/veterinary ; Animals ; Antihypertensive Agents/administration & dosage ; Craniotomy/veterinary ; Heart Rate/drug effects ; Hypertension/drug therapy ; Intraoperative Complications/drug therapy ; Intraoperative Complications/veterinary ; Labetalol/administration & dosage ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of nitroglycerin versus labetalol on peripheral perfusion during deliberate hypotension for sinus endoscopic surgery: a randomized, controlled, double-blinded trial.
Autorzy:
Zayed M; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt. .; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, 11559, Egypt. .
Nassar H; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Hasanin A; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Saleh AH; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Hassan P; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Saad D; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, 11559, Egypt.
Mahmoud S; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, 11559, Egypt.
Abo Bakr G; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, 11559, Egypt.
Fouad E; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Saleh N; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, 11559, Egypt.
Ismail M; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
El-Hadi H; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, 11559, Egypt.
Pokaż więcej
Źródło:
BMC anesthesiology [BMC Anesthesiol] 2020 Apr 17; Vol. 20 (1), pp. 85. Date of Electronic Publication: 2020 Apr 17.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Endoscopy/*methods
Hypotension, Controlled/*methods
Labetalol/*administration & dosage
Nitroglycerin/*administration & dosage
Adult ; Antihypertensive Agents/administration & dosage ; Antihypertensive Agents/pharmacology ; Double-Blind Method ; Female ; Humans ; Labetalol/pharmacology ; Lactic Acid/blood ; Male ; Nitroglycerin/pharmacology ; Paranasal Sinuses/surgery ; Perfusion Index ; Pilot Projects ; Vasodilator Agents/administration & dosage ; Vasodilator Agents/pharmacology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety of high-dose intravenous labetalol in hypertensive crisis.
Autorzy:
Hecht JP; Department of Pharmacy, St. Joseph Mercy Hospital, Ann Arbor, MI.
Mahmood SM; Department of Pharmacy, Beaumont Hospital, Dearborn, MI.
Brandt MM; Department of Surgery, St. Joseph Mercy Hospital, Ann Arbor, MI.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2019 Feb 09; Vol. 76 (5), pp. 286-292.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Antihypertensive Agents/*administration & dosage
Blood Pressure/*drug effects
Heart Rate/*drug effects
Hypertension/*drug therapy
Labetalol/*administration & dosage
Administration, Intravenous ; Adult ; Aged ; Antihypertensive Agents/adverse effects ; Blood Pressure/physiology ; Bradycardia/chemically induced ; Bradycardia/diagnosis ; Dose-Response Relationship, Drug ; Female ; Heart Rate/physiology ; Humans ; Hypertension/diagnosis ; Hypotension/chemically induced ; Hypotension/diagnosis ; Labetalol/adverse effects ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1288

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies